Overview

Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
To estimate and compare the response rates in patients treated with mDCF based on methylation status of CHFR.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Treatments:
Carboplatin
Docetaxel
Fluorouracil
Leucovorin